nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—CYP3A5—prostate cancer	0.205	0.425	CbGaD
Levomethadyl Acetate—CYP19A1—prostate cancer	0.189	0.391	CbGaD
Levomethadyl Acetate—CYP3A4—prostate cancer	0.0889	0.184	CbGaD
Levomethadyl Acetate—CYP3A5—Flutamide—prostate cancer	0.0425	0.105	CbGbCtD
Levomethadyl Acetate—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0381	0.0943	CbGbCtD
Levomethadyl Acetate—CYP3A5—Cabazitaxel—prostate cancer	0.0314	0.0779	CbGbCtD
Levomethadyl Acetate—CYP3A5—Estrone—prostate cancer	0.0307	0.0761	CbGbCtD
Levomethadyl Acetate—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0235	0.0583	CbGbCtD
Levomethadyl Acetate—CYP3A7—Estradiol—prostate cancer	0.0235	0.0583	CbGbCtD
Levomethadyl Acetate—CYP3A4—Bicalutamide—prostate cancer	0.02	0.0495	CbGbCtD
Levomethadyl Acetate—CYP3A4—Estramustine—prostate cancer	0.0186	0.0461	CbGbCtD
Levomethadyl Acetate—CYP3A5—Estradiol—prostate cancer	0.0177	0.0437	CbGbCtD
Levomethadyl Acetate—CYP3A4—Abiraterone—prostate cancer	0.0166	0.0411	CbGbCtD
Levomethadyl Acetate—CYP3A4—Flutamide—prostate cancer	0.0166	0.0411	CbGbCtD
Levomethadyl Acetate—CYP3A7—Docetaxel—prostate cancer	0.0141	0.0348	CbGbCtD
Levomethadyl Acetate—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.0141	0.0348	CbGbCtD
Levomethadyl Acetate—CYP3A4—Cabazitaxel—prostate cancer	0.0123	0.0304	CbGbCtD
Levomethadyl Acetate—CYP3A4—Estrone—prostate cancer	0.012	0.0297	CbGbCtD
Levomethadyl Acetate—CYP3A5—Etoposide—prostate cancer	0.0115	0.0285	CbGbCtD
Levomethadyl Acetate—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0107	0.0265	CbGbCtD
Levomethadyl Acetate—CYP3A5—Docetaxel—prostate cancer	0.0105	0.0261	CbGbCtD
Levomethadyl Acetate—CYP3A4—Conjugated Estrogens—prostate cancer	0.00784	0.0194	CbGbCtD
Levomethadyl Acetate—CYP3A4—Mitoxantrone—prostate cancer	0.00713	0.0176	CbGbCtD
Levomethadyl Acetate—CYP3A4—Estradiol—prostate cancer	0.00688	0.017	CbGbCtD
Levomethadyl Acetate—CYP3A4—Prednisone—prostate cancer	0.00592	0.0147	CbGbCtD
Levomethadyl Acetate—CYP3A4—Etoposide—prostate cancer	0.00449	0.0111	CbGbCtD
Levomethadyl Acetate—CYP3A4—Docetaxel—prostate cancer	0.00411	0.0102	CbGbCtD
Levomethadyl Acetate—CYP19A1—semen—prostate cancer	0.00332	0.287	CbGeAlD
Levomethadyl Acetate—CYP3A4—Doxorubicin—prostate cancer	0.00307	0.00759	CbGbCtD
Levomethadyl Acetate—CHRNA3—prostate gland—prostate cancer	0.00163	0.141	CbGeAlD
Levomethadyl Acetate—CHRNB4—testis—prostate cancer	0.00117	0.101	CbGeAlD
Levomethadyl Acetate—CYP3A4—urine—prostate cancer	0.00112	0.0973	CbGeAlD
Levomethadyl Acetate—CYP19A1—prostate gland—prostate cancer	0.000832	0.072	CbGeAlD
Levomethadyl Acetate—CHRNA3—testis—prostate cancer	0.000716	0.062	CbGeAlD
Levomethadyl Acetate—CYP3A5—prostate gland—prostate cancer	0.000537	0.0465	CbGeAlD
Levomethadyl Acetate—CHRNA3—lymph node—prostate cancer	0.000519	0.0449	CbGeAlD
Levomethadyl Acetate—Tamoxifen—SULT1A1—prostate cancer	0.000463	0.134	CrCbGaD
Levomethadyl Acetate—OPRM1—testis—prostate cancer	0.000436	0.0378	CbGeAlD
Levomethadyl Acetate—CYP19A1—testis—prostate cancer	0.000366	0.0317	CbGeAlD
Levomethadyl Acetate—CYP3A5—renal system—prostate cancer	0.000366	0.0317	CbGeAlD
Levomethadyl Acetate—CYP3A4—renal system—prostate cancer	0.000275	0.0238	CbGeAlD
Levomethadyl Acetate—CYP19A1—lymph node—prostate cancer	0.000266	0.023	CbGeAlD
Levomethadyl Acetate—Disopyramide—SLC22A1—prostate cancer	0.000243	0.0706	CrCbGaD
Levomethadyl Acetate—Phenoxybenzamine—SLC22A3—prostate cancer	0.0002	0.0582	CrCbGaD
Levomethadyl Acetate—Diphenhydramine—CYP2C18—prostate cancer	0.000147	0.0428	CrCbGaD
Levomethadyl Acetate—Phenoxybenzamine—SLC22A1—prostate cancer	0.000144	0.0417	CrCbGaD
Levomethadyl Acetate—Methadone—CYP2C18—prostate cancer	0.000142	0.0414	CrCbGaD
Levomethadyl Acetate—Modafinil—CYP3A5—prostate cancer	0.00014	0.0406	CrCbGaD
Levomethadyl Acetate—Tamoxifen—ESR2—prostate cancer	0.00013	0.0378	CrCbGaD
Levomethadyl Acetate—Diphenhydramine—SLC22A1—prostate cancer	0.00012	0.035	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP1B1—prostate cancer	0.000119	0.0345	CrCbGaD
Levomethadyl Acetate—Modafinil—CYP2C19—prostate cancer	9.52e-05	0.0276	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP3A5—prostate cancer	9.46e-05	0.0275	CrCbGaD
Levomethadyl Acetate—Methadone—CYP3A5—prostate cancer	9.38e-05	0.0272	CrCbGaD
Levomethadyl Acetate—Phenoxybenzamine—ADRB2—prostate cancer	9.16e-05	0.0266	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP2A6—prostate cancer	9.15e-05	0.0266	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP19A1—prostate cancer	8.72e-05	0.0253	CrCbGaD
Levomethadyl Acetate—Methadone—CYP19A1—prostate cancer	8.64e-05	0.0251	CrCbGaD
Levomethadyl Acetate—Disopyramide—CYP3A4—prostate cancer	8.49e-05	0.0247	CrCbGaD
Levomethadyl Acetate—Tamoxifen—ESR1—prostate cancer	8.02e-05	0.0233	CrCbGaD
Levomethadyl Acetate—Diphenhydramine—CYP2C19—prostate cancer	6.61e-05	0.0192	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP2E1—prostate cancer	6.5e-05	0.0189	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP2C19—prostate cancer	6.44e-05	0.0187	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP1A1—prostate cancer	6.41e-05	0.0186	CrCbGaD
Levomethadyl Acetate—Methadone—CYP2C19—prostate cancer	6.38e-05	0.0185	CrCbGaD
Levomethadyl Acetate—Orphenadrine—CYP2E1—prostate cancer	6.31e-05	0.0183	CrCbGaD
Levomethadyl Acetate—Modafinil—CYP3A4—prostate cancer	6.05e-05	0.0176	CrCbGaD
Levomethadyl Acetate—Dextropropoxyphene—CYP3A4—prostate cancer	5.98e-05	0.0174	CrCbGaD
Levomethadyl Acetate—Loperamide—CYP3A4—prostate cancer	5.7e-05	0.0166	CrCbGaD
Levomethadyl Acetate—Benzphetamine—CYP3A4—prostate cancer	5.25e-05	0.0152	CrCbGaD
Levomethadyl Acetate—Phenoxybenzamine—CYP3A4—prostate cancer	5.01e-05	0.0146	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP3A4—prostate cancer	4.09e-05	0.0119	CrCbGaD
Levomethadyl Acetate—Methadone—CYP3A4—prostate cancer	4.06e-05	0.0118	CrCbGaD
Levomethadyl Acetate—Orphenadrine—CYP3A4—prostate cancer	3.98e-05	0.0116	CrCbGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NAT1—prostate cancer	8.19e-06	8.4e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—DEGS1—prostate cancer	8.19e-06	8.4e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ITPR1—prostate cancer	8.13e-06	8.34e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NCOA3—prostate cancer	8.08e-06	8.3e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PIK3CG—prostate cancer	8.06e-06	8.27e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.99e-06	8.2e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GGT1—prostate cancer	7.99e-06	8.2e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CASP9—prostate cancer	7.96e-06	8.17e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NCOA1—prostate cancer	7.87e-06	8.07e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—HSD17B1—prostate cancer	7.81e-06	8.02e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CD—prostate cancer	7.8e-06	8e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP19A1—prostate cancer	7.75e-06	7.96e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PRKCQ—prostate cancer	7.72e-06	7.92e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NGFR—prostate cancer	7.72e-06	7.92e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—HPGDS—prostate cancer	7.71e-06	7.92e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—TYMS—prostate cancer	7.68e-06	7.88e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP2C19—prostate cancer	7.66e-06	7.87e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MAP3K7—prostate cancer	7.63e-06	7.83e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTM1—prostate cancer	7.59e-06	7.79e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—RXRA—prostate cancer	7.48e-06	7.68e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTT1—prostate cancer	7.48e-06	7.68e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ACHE—prostate cancer	7.48e-06	7.68e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—LPL—prostate cancer	7.45e-06	7.65e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP2A6—prostate cancer	7.39e-06	7.59e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—FGF10—prostate cancer	7.33e-06	7.53e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ADRB2—prostate cancer	7.26e-06	7.45e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—COMT—prostate cancer	7.21e-06	7.4e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CYP1A1—prostate cancer	7.2e-06	7.39e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—AKR1C3—prostate cancer	7.19e-06	7.38e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTP1—prostate cancer	7.17e-06	7.36e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—JAK2—prostate cancer	7.16e-06	7.35e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PRKACB—prostate cancer	7.16e-06	7.34e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ERCC2—prostate cancer	7.14e-06	7.33e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—MAP2K1—prostate cancer	7.13e-06	7.32e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PIK3CD—prostate cancer	7.08e-06	7.27e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP17A1—prostate cancer	7.08e-06	7.27e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—VAV3—prostate cancer	7.07e-06	7.26e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ITPR1—prostate cancer	7.06e-06	7.24e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TGFBR2—prostate cancer	6.97e-06	7.16e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—HPGD—prostate cancer	6.96e-06	7.14e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.96e-06	7.14e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ITPR1—prostate cancer	6.86e-06	7.04e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CB—prostate cancer	6.8e-06	6.98e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NCOA2—prostate cancer	6.75e-06	6.93e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—MTHFR—prostate cancer	6.71e-06	6.89e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—TYMS—prostate cancer	6.67e-06	6.84e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTM1—prostate cancer	6.59e-06	6.77e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PPARA—prostate cancer	6.58e-06	6.76e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF1R—prostate cancer	6.56e-06	6.73e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TNFRSF21—prostate cancer	6.54e-06	6.72e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CXCL8—prostate cancer	6.53e-06	6.7e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—JAK2—prostate cancer	6.5e-06	6.67e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—LPL—prostate cancer	6.47e-06	6.64e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SLC5A5—prostate cancer	6.44e-06	6.61e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP7B1—prostate cancer	6.37e-06	6.53e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MTAP—prostate cancer	6.37e-06	6.53e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—LPL—prostate cancer	6.29e-06	6.46e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP2E1—prostate cancer	6.29e-06	6.45e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP1A1—prostate cancer	6.25e-06	6.41e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—IL2—prostate cancer	6.24e-06	6.41e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PDGFRB—prostate cancer	6.23e-06	6.4e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NQO1—prostate cancer	6.22e-06	6.38e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SULT1E1—prostate cancer	6.2e-06	6.37e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SRD5A1—prostate cancer	6.2e-06	6.37e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ERCC2—prostate cancer	6.2e-06	6.36e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CAV1—prostate cancer	6.19e-06	6.35e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PIK3CB—prostate cancer	6.17e-06	6.34e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TH—prostate cancer	6.13e-06	6.29e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ITGB3—prostate cancer	6.08e-06	6.24e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP3A4—prostate cancer	6.06e-06	6.22e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP1B1—prostate cancer	5.96e-06	6.12e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CXCL8—prostate cancer	5.93e-06	6.09e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ACSL4—prostate cancer	5.92e-06	6.07e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.92e-06	6.07e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.91e-06	6.07e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ERBB3—prostate cancer	5.89e-06	6.05e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—FGFR2—prostate cancer	5.88e-06	6.04e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—MTHFR—prostate cancer	5.83e-06	5.98e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GGT1—prostate cancer	5.77e-06	5.93e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PPARA—prostate cancer	5.72e-06	5.87e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NCOA1—prostate cancer	5.69e-06	5.84e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PHGDH—prostate cancer	5.67e-06	5.82e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ARG2—prostate cancer	5.67e-06	5.82e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—UMPS—prostate cancer	5.67e-06	5.82e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL2—prostate cancer	5.67e-06	5.82e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TERT—prostate cancer	5.65e-06	5.8e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PIK3CG—prostate cancer	5.64e-06	5.79e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP19A1—prostate cancer	5.6e-06	5.75e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—LDHB—prostate cancer	5.56e-06	5.71e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.46e-06	5.61e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—RXRA—prostate cancer	5.41e-06	5.55e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HIF1A—prostate cancer	5.4e-06	5.54e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CAV1—prostate cancer	5.37e-06	5.52e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—INS—prostate cancer	5.34e-06	5.48e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PDHA1—prostate cancer	5.27e-06	5.41e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—UCP3—prostate cancer	5.27e-06	5.41e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TCN2—prostate cancer	5.27e-06	5.41e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTA3—prostate cancer	5.27e-06	5.41e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—LEP—prostate cancer	5.27e-06	5.41e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CREBBP—prostate cancer	5.23e-06	5.36e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CAV1—prostate cancer	5.22e-06	5.36e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—COMT—prostate cancer	5.21e-06	5.35e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTP1—prostate cancer	5.19e-06	5.32e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—KDR—prostate cancer	5.17e-06	5.3e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ITPR1—prostate cancer	5.1e-06	5.24e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ESR1—prostate cancer	5.03e-06	5.17e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.03e-06	5.17e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.03e-06	5.17e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PIK3CD—prostate cancer	4.96e-06	5.09e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—BAD—prostate cancer	4.91e-06	5.04e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PIK3CG—prostate cancer	4.89e-06	5.02e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTA4—prostate cancer	4.82e-06	4.95e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.82e-06	4.95e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TYMS—prostate cancer	4.82e-06	4.95e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTM1—prostate cancer	4.76e-06	4.89e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PIK3CG—prostate cancer	4.76e-06	4.88e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—APC—prostate cancer	4.76e-06	4.88e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IRS1—prostate cancer	4.7e-06	4.83e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—EGF—prostate cancer	4.7e-06	4.83e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTA2—prostate cancer	4.7e-06	4.83e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NOS3—prostate cancer	4.68e-06	4.8e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—LPL—prostate cancer	4.68e-06	4.8e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ABCG5—prostate cancer	4.64e-06	4.77e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.64e-06	4.77e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—INS—prostate cancer	4.63e-06	4.76e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GSK3B—prostate cancer	4.57e-06	4.69e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CREBBP—prostate cancer	4.54e-06	4.66e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTA1—prostate cancer	4.54e-06	4.66e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP1A1—prostate cancer	4.52e-06	4.64e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—INS—prostate cancer	4.5e-06	4.62e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.49e-06	4.6e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTO1—prostate cancer	4.49e-06	4.6e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NAT2—prostate cancer	4.49e-06	4.6e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ERCC2—prostate cancer	4.48e-06	4.6e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CREBBP—prostate cancer	4.41e-06	4.53e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF1—prostate cancer	4.36e-06	4.47e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—EGFR—prostate cancer	4.34e-06	4.45e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PIK3CB—prostate cancer	4.32e-06	4.43e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PIK3CD—prostate cancer	4.3e-06	4.42e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.3e-06	4.41e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PLCB2—prostate cancer	4.3e-06	4.41e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—LRP2—prostate cancer	4.3e-06	4.41e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTGS2—prostate cancer	4.28e-06	4.39e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—P4HB—prostate cancer	4.22e-06	4.33e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	4.21e-06	4.32e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—MTHFR—prostate cancer	4.21e-06	4.32e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	4.18e-06	4.29e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	4.14e-06	4.25e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	4.14e-06	4.25e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PPARA—prostate cancer	4.13e-06	4.24e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.1e-06	4.21e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—KRAS—prostate cancer	4.1e-06	4.2e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NOS3—prostate cancer	4.06e-06	4.17e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—FGF2—prostate cancer	4.01e-06	4.11e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SULT2A1—prostate cancer	4e-06	4.1e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NOS3—prostate cancer	3.95e-06	4.05e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MED12—prostate cancer	3.93e-06	4.04e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GNG5—prostate cancer	3.9e-06	4.01e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CAV1—prostate cancer	3.88e-06	3.99e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—JAK2—prostate cancer	3.84e-06	3.94e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	3.76e-06	3.86e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NCOA3—prostate cancer	3.76e-06	3.86e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PIK3CB—prostate cancer	3.75e-06	3.85e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MDM2—prostate cancer	3.75e-06	3.85e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTEN—prostate cancer	3.73e-06	3.83e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTGS2—prostate cancer	3.72e-06	3.81e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ERBB2—prostate cancer	3.69e-06	3.79e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	3.65e-06	3.74e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—HPGDS—prostate cancer	3.59e-06	3.68e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.56e-06	3.66e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—EP300—prostate cancer	3.56e-06	3.65e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PIK3CG—prostate cancer	3.54e-06	3.63e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CXCL8—prostate cancer	3.5e-06	3.6e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTT1—prostate cancer	3.48e-06	3.57e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ACHE—prostate cancer	3.48e-06	3.57e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.44e-06	3.53e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	3.42e-06	3.51e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	3.39e-06	3.47e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CASP3—prostate cancer	3.35e-06	3.44e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—INS—prostate cancer	3.35e-06	3.44e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL2—prostate cancer	3.35e-06	3.44e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.34e-06	3.43e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL6—prostate cancer	3.33e-06	3.42e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PRKACB—prostate cancer	3.33e-06	3.41e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.29e-06	3.38e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CREBBP—prostate cancer	3.28e-06	3.37e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCND1—prostate cancer	3.26e-06	3.35e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTEN—prostate cancer	3.24e-06	3.33e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	3.23e-06	3.32e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MMP9—prostate cancer	3.17e-06	3.25e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	3.16e-06	3.24e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PTEN—prostate cancer	3.15e-06	3.23e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NCOA2—prostate cancer	3.14e-06	3.22e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PIK3CD—prostate cancer	3.11e-06	3.19e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—EP300—prostate cancer	3.09e-06	3.17e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—AKT1—prostate cancer	3.07e-06	3.16e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—EP300—prostate cancer	3e-06	3.08e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.99e-06	3.07e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NOS3—prostate cancer	2.94e-06	3.01e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.92e-06	3e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SRC—prostate cancer	2.92e-06	3e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NQO1—prostate cancer	2.89e-06	2.97e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TH—prostate cancer	2.85e-06	2.92e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—VEGFA—prostate cancer	2.85e-06	2.92e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—STAT3—prostate cancer	2.82e-06	2.89e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.77e-06	2.84e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PIK3CB—prostate cancer	2.71e-06	2.78e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTGS2—prostate cancer	2.69e-06	2.76e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GGT1—prostate cancer	2.68e-06	2.75e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NCOA1—prostate cancer	2.64e-06	2.71e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PIK3CA—prostate cancer	2.63e-06	2.7e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MYC—prostate cancer	2.62e-06	2.69e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TGFB1—prostate cancer	2.61e-06	2.68e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.61e-06	2.67e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—EGFR—prostate cancer	2.56e-06	2.63e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—RXRA—prostate cancer	2.51e-06	2.58e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—COMT—prostate cancer	2.42e-06	2.49e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—KRAS—prostate cancer	2.42e-06	2.48e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTP1—prostate cancer	2.41e-06	2.47e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ITPR1—prostate cancer	2.37e-06	2.43e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTEN—prostate cancer	2.34e-06	2.4e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PIK3CA—prostate cancer	2.29e-06	2.35e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TYMS—prostate cancer	2.24e-06	2.3e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—EP300—prostate cancer	2.23e-06	2.29e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	2.22e-06	2.28e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTM1—prostate cancer	2.22e-06	2.27e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—LPL—prostate cancer	2.17e-06	2.23e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—AKT1—prostate cancer	2.15e-06	2.21e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TP53—prostate cancer	2.15e-06	2.21e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.1e-06	2.16e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ERCC2—prostate cancer	2.08e-06	2.14e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL6—prostate cancer	1.97e-06	2.02e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MTHFR—prostate cancer	1.96e-06	2.01e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PPARA—prostate cancer	1.92e-06	1.97e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—AKT1—prostate cancer	1.87e-06	1.92e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AKT1—prostate cancer	1.82e-06	1.86e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CAV1—prostate cancer	1.81e-06	1.85e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.65e-06	1.7e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.64e-06	1.69e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—INS—prostate cancer	1.56e-06	1.6e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CREBBP—prostate cancer	1.53e-06	1.57e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.45e-06	1.48e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NOS3—prostate cancer	1.37e-06	1.4e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—AKT1—prostate cancer	1.35e-06	1.39e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.26e-06	1.29e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTGS2—prostate cancer	1.25e-06	1.28e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTEN—prostate cancer	1.09e-06	1.12e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—EP300—prostate cancer	1.04e-06	1.07e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.68e-07	7.89e-06	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—AKT1—prostate cancer	6.28e-07	6.44e-06	CbGpPWpGaD
